Tarrytown

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease2 trials
• Macular degeneration2 trials

Status

• Completed2 trials

Lead sponsor

• Regeneron Pharmaceuticals2 trials

Closed trials

• Completed

  Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

  NCT07105228· Regeneron Pharmaceuticals· Source

• Completed

  A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)

  NCT06769412· Regeneron Pharmaceuticals· Source